ID   PASK_HUMAN              Reviewed;        1323 AA.
AC   Q96RG2; G5E9F1; Q05BE4; Q68DY3; Q6GSJ5; Q86XH6; Q99763; Q9UFR7;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   12-OCT-2022, entry version 204.
DE   RecName: Full=PAS domain-containing serine/threonine-protein kinase;
DE            Short=PAS-kinase;
DE            Short=PASKIN;
DE            Short=hPASK;
DE            EC=2.7.11.1;
GN   Name=PASK; Synonyms=KIAA0135;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PHOSPHORYLATION AT THR-1161 AND
RP   THR-1165, MUTAGENESIS OF LYS-1028; THR-1161 AND THR-1165, AND VARIANT
RP   CYS-1266.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=11459942; DOI=10.1073/pnas.161284798;
RA   Rutter J., Michnoff C.H., Harper S.M., Gardner K.H., McKnight S.L.;
RT   "PAS kinase: an evolutionarily conserved PAS domain-regulated
RT   serine/threonine kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8991-8996(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS MET-694
RP   AND CYS-1266.
RC   TISSUE=Bone marrow;
RX   PubMed=8590280; DOI=10.1093/dnares/2.4.167;
RA   Nagase T., Seki N., Tanaka A., Ishikawa K., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. IV. The
RT   coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:167-174(1995).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   ILE-250.
RC   TISSUE=Eye, Lymph, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 866-1323 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9110174; DOI=10.1101/gr.7.4.353;
RA   Yu W., Andersson B., Worley K.C., Muzny D.M., Ding Y., Liu W.,
RA   Ricafrente J.Y., Wentland M.A., Lennon G., Gibbs R.A.;
RT   "Large-scale concatenation cDNA sequencing.";
RL   Genome Res. 7:353-358(1997).
RN   [9]
RP   FUNCTION IN PHOSPHORYLATION OF GYS1.
RX   PubMed=16275910; DOI=10.1073/pnas.0508481102;
RA   Wilson W.A., Skurat A.V., Probst B., de Paoli-Roach A., Roach P.J.,
RA   Rutter J.;
RT   "Control of mammalian glycogen synthase by PAS kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:16596-16601(2005).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF PDX1.
RX   PubMed=17052199; DOI=10.1042/bst0340791;
RA   An R., da Silva Xavier G., Hao H.X., Semplici F., Rutter J., Rutter G.A.;
RT   "Regulation by Per-Arnt-Sim (PAS) kinase of pancreatic duodenal homeobox-1
RT   nuclear import in pancreatic beta-cells.";
RL   Biochem. Soc. Trans. 34:791-793(2006).
RN   [11]
RP   FUNCTION IN PHOSPHORYLATION OF EEF1A1, AUTOPHOSPHORYLATION, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF THR-1161 AND THR-1165.
RX   PubMed=17595531; DOI=10.1159/000104169;
RA   Eckhardt K., Troger J., Reissmann J., Katschinski D.M., Wagner K.F.,
RA   Stengel P., Paasch U., Hunziker P., Borter E., Barth S., Schlafli P.,
RA   Spielmann P., Stiehl D.P., Camenisch G., Wenger R.H.;
RT   "Male germ cell expression of the PAS domain kinase PASKIN and its novel
RT   target eukaryotic translation elongation factor eEF1A1.";
RL   Cell. Physiol. Biochem. 20:227-240(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   FUNCTION.
RX   PubMed=21181396; DOI=10.1007/s00125-010-2010-7;
RA   da Silva Xavier G., Farhan H., Kim H., Caxaria S., Johnson P., Hughes S.,
RA   Bugliani M., Marselli L., Marchetti P., Birzele F., Sun G., Scharfmann R.,
RA   Rutter J., Siniakowicz K., Weir G., Parker H., Reimann F., Gribble F.M.,
RA   Rutter G.A.;
RT   "Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in
RT   human islets in type 2 diabetes and regulates glucagon secretion.";
RL   Diabetologia 54:819-827(2011).
RN   [15]
RP   FUNCTION IN PHOSPHORYLATION OF RPS6, ACTIVITY REGULATION, DOMAIN PROTEIN
RP   KINASE, AUTOPHOSPHORYLATION, AND LIPID-BINDING.
RX   PubMed=21418524; DOI=10.1111/j.1742-4658.2011.08100.x;
RA   Schlafli P., Troger J., Eckhardt K., Borter E., Spielmann P., Wenger R.H.;
RT   "Substrate preference and phosphatidylinositol monophosphate inhibition of
RT   the catalytic domain of the Per-Arnt-Sim domain kinase PASKIN.";
RL   FEBS J. 278:1757-1768(2011).
RN   [16]
RP   REVIEW ON FUNCTION.
RX   PubMed=19189049; DOI=10.1007/s00018-009-8699-0;
RA   Schlafli P., Borter E., Spielmann P., Wenger R.H.;
RT   "The PAS-domain kinase PASKIN: a new sensor in energy homeostasis.";
RL   Cell. Mol. Life Sci. 66:876-883(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582 AND SER-939, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   STRUCTURE BY NMR OF 131-237.
RX   PubMed=12377121; DOI=10.1016/s0969-2126(02)00857-2;
RA   Amezcua C.A., Harper S.M., Rutter J., Gardner K.H.;
RT   "Structure and interactions of PAS kinase N-terminal PAS domain: model for
RT   intramolecular kinase regulation.";
RL   Structure 10:1349-1361(2002).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 977-1300 IN COMPLEX WITH ADP,
RP   AUTOPHOSPHORYLATION, FUNCTION, AND MUTAGENESIS OF LYS-1028; ARG-1058;
RP   ALA-1151; TYR-1152 AND THR-1161.
RX   PubMed=20943661; DOI=10.1074/jbc.m110.157594;
RA   Kikani C.K., Antonysamy S.A., Bonanno J.B., Romero R., Zhang F.F.,
RA   Russell M., Gheyi T., Iizuka M., Emtage S., Sauder J.M., Turk B.E.,
RA   Burley S.K., Rutter J.;
RT   "Structural bases of PAS domain-regulated kinase (PASK) activation in the
RT   absence of activation loop phosphorylation.";
RL   J. Biol. Chem. 285:41034-41043(2010).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-11; ILE-250; ARG-426; ALA-512; SER-514;
RP   ARG-684; ASP-725; LYS-796; GLN-844; HIS-937; MET-1210; CYS-1266 AND
RP   SER-1301.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in energy
CC       homeostasis and protein translation. Phosphorylates EEF1A1, GYS1, PDX1
CC       and RPS6. Probably plays a role under changing environmental conditions
CC       (oxygen, glucose, nutrition), rather than under standard conditions.
CC       Acts as a sensor involved in energy homeostasis: regulates glycogen
CC       synthase synthesis by mediating phosphorylation of GYS1, leading to
CC       GYS1 inactivation. May be involved in glucose-stimulated insulin
CC       production in pancreas and regulation of glucagon secretion by glucose
CC       in alpha cells; however such data require additional evidences. May
CC       play a role in regulation of protein translation by phosphorylating
CC       EEF1A1, leading to increase translation efficiency. May also
CC       participate in respiratory regulation. {ECO:0000269|PubMed:16275910,
CC       ECO:0000269|PubMed:17052199, ECO:0000269|PubMed:17595531,
CC       ECO:0000269|PubMed:20943661, ECO:0000269|PubMed:21181396,
CC       ECO:0000269|PubMed:21418524}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Protein kinase activity is inhibited by the first
CC       PAS domain: binding of an unidentified ligand desinhibits the protein
CC       kinase activity. May be activated by autophosphorylation on Thr-1161
CC       and Thr-1165 (PubMed:11459942). The activating role of
CC       autophosphorylation at Thr-1161 is unclear: according to a report,
CC       autophosphorylation at Thr-1161 does not play a major role in
CC       activation (PubMed:20943661). Autophosphorylation is enhanced upon
CC       phosphatidylinositol monophosphate (phosphatidylinositol 4-phosphate)
CC       binding and inhibited upon phosphatidylinositol bi- and tri-phosphate
CC       binding. In contrast, phosphorylation of target proteins is inhibited
CC       upon all phosphatidylinositol-binding (phosphatidylinositol
CC       mono- bi- and tri-phosphate). {ECO:0000269|PubMed:11459942,
CC       ECO:0000269|PubMed:20943661, ECO:0000269|PubMed:21418524}.
CC   -!- INTERACTION:
CC       Q96RG2; P16220: CREB1; NbExp=2; IntAct=EBI-1042651, EBI-711855;
CC       Q96RG2; P02545: LMNA; NbExp=2; IntAct=EBI-1042651, EBI-351935;
CC       Q96RG2; Q93100: PHKB; NbExp=2; IntAct=EBI-1042651, EBI-740559;
CC       Q96RG2; P62753: RPS6; NbExp=3; IntAct=EBI-1042651, EBI-356625;
CC       Q96RG2; P07293: CACNA1S; Xeno; NbExp=2; IntAct=EBI-1042651, EBI-8613624;
CC       Q96RG2; P02542: DES; Xeno; NbExp=2; IntAct=EBI-1042651, EBI-8614455;
CC       Q96RG2; Q28115: GFAP; Xeno; NbExp=2; IntAct=EBI-1042651, EBI-907866;
CC       Q96RG2; P02646: TNNI3; Xeno; NbExp=2; IntAct=EBI-1042651, EBI-8614386;
CC       Q96RG2; P20152: Vim; Xeno; NbExp=2; IntAct=EBI-1042651, EBI-299269;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17595531}. Nucleus
CC       {ECO:0000269|PubMed:17595531}. Note=Localizes in the nucleus of testis
CC       germ cells and in the midpiece of sperm tails.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96RG2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96RG2-2; Sequence=VSP_009302;
CC       Name=3;
CC         IsoId=Q96RG2-4; Sequence=VSP_045543, VSP_045544;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with slightly higher
CC       expression in brain, prostate and testis. Reduced expression was found
CC       in placenta. Present in germ cells of testis and in the midpiece of
CC       sperm tails (at protein level).
CC   -!- DOMAIN: The protein kinase domain mediates binding to
CC       phosphatidylinositol. {ECO:0000269|PubMed:21418524}.
CC   -!- PTM: Autophosphorylated on Thr-1161 and Thr-1165. Autophosphorylation
CC       is activated by phospholipids. {ECO:0000269|PubMed:11459942}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA09484.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF387103; AAK69752.1; -; mRNA.
DR   EMBL; D50925; BAA09484.2; ALT_INIT; mRNA.
DR   EMBL; CR749231; CAH18087.1; -; mRNA.
DR   EMBL; AC005237; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW71238.1; -; Genomic_DNA.
DR   EMBL; BC043495; AAH43495.1; -; mRNA.
DR   EMBL; BC050565; AAH50565.1; -; mRNA.
DR   EMBL; BC063585; AAH63585.1; -; mRNA.
DR   EMBL; U79240; AAB50198.1; -; mRNA.
DR   CCDS; CCDS2545.1; -. [Q96RG2-1]
DR   CCDS; CCDS58758.1; -. [Q96RG2-4]
DR   CCDS; CCDS58759.1; -. [Q96RG2-2]
DR   PIR; T17211; T17211.
DR   RefSeq; NP_001239048.1; NM_001252119.1. [Q96RG2-2]
DR   RefSeq; NP_001239049.1; NM_001252120.1. [Q96RG2-1]
DR   RefSeq; NP_001239051.1; NM_001252122.1.
DR   RefSeq; NP_001239053.1; NM_001252124.1. [Q96RG2-4]
DR   RefSeq; NP_055963.2; NM_015148.3. [Q96RG2-1]
DR   RefSeq; XP_011509130.1; XM_011510828.1. [Q96RG2-2]
DR   RefSeq; XP_011509131.1; XM_011510829.1. [Q96RG2-2]
DR   RefSeq; XP_011509132.1; XM_011510830.1. [Q96RG2-2]
DR   RefSeq; XP_016859124.1; XM_017003635.1. [Q96RG2-1]
DR   RefSeq; XP_016859125.1; XM_017003636.1. [Q96RG2-1]
DR   PDB; 1LL8; NMR; -; A=131-237.
DR   PDB; 3DLS; X-ray; 2.30 A; A/B/C/D/E/F=977-1300.
DR   PDBsum; 1LL8; -.
DR   PDBsum; 3DLS; -.
DR   AlphaFoldDB; Q96RG2; -.
DR   BMRB; Q96RG2; -.
DR   SMR; Q96RG2; -.
DR   BioGRID; 116790; 157.
DR   IntAct; Q96RG2; 78.
DR   MINT; Q96RG2; -.
DR   STRING; 9606.ENSP00000351475; -.
DR   BindingDB; Q96RG2; -.
DR   ChEMBL; CHEMBL6054; -.
DR   MoonDB; Q96RG2; Predicted.
DR   GlyGen; Q96RG2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q96RG2; -.
DR   PhosphoSitePlus; Q96RG2; -.
DR   BioMuta; PASK; -.
DR   DMDM; 116242701; -.
DR   EPD; Q96RG2; -.
DR   jPOST; Q96RG2; -.
DR   MassIVE; Q96RG2; -.
DR   MaxQB; Q96RG2; -.
DR   PaxDb; Q96RG2; -.
DR   PeptideAtlas; Q96RG2; -.
DR   PRIDE; Q96RG2; -.
DR   ProteomicsDB; 33919; -.
DR   ProteomicsDB; 77959; -. [Q96RG2-1]
DR   ProteomicsDB; 77960; -. [Q96RG2-2]
DR   Antibodypedia; 20301; 219 antibodies from 28 providers.
DR   DNASU; 23178; -.
DR   Ensembl; ENST00000234040.9; ENSP00000234040.5; ENSG00000115687.14. [Q96RG2-1]
DR   Ensembl; ENST00000358649.8; ENSP00000351475.4; ENSG00000115687.14. [Q96RG2-2]
DR   Ensembl; ENST00000403638.7; ENSP00000384438.3; ENSG00000115687.14. [Q96RG2-4]
DR   Ensembl; ENST00000405260.5; ENSP00000384016.1; ENSG00000115687.14. [Q96RG2-1]
DR   Ensembl; ENST00000544142.5; ENSP00000441374.2; ENSG00000115687.14. [Q96RG2-1]
DR   GeneID; 23178; -.
DR   KEGG; hsa:23178; -.
DR   MANE-Select; ENST00000234040.9; ENSP00000234040.5; NM_015148.4; NP_055963.2.
DR   UCSC; uc002wao.2; human. [Q96RG2-1]
DR   CTD; 23178; -.
DR   DisGeNET; 23178; -.
DR   GeneCards; PASK; -.
DR   HGNC; HGNC:17270; PASK.
DR   HPA; ENSG00000115687; Tissue enhanced (brain, lymphoid tissue).
DR   MIM; 607505; gene.
DR   neXtProt; NX_Q96RG2; -.
DR   OpenTargets; ENSG00000115687; -.
DR   PharmGKB; PA32953; -.
DR   VEuPathDB; HostDB:ENSG00000115687; -.
DR   eggNOG; KOG0583; Eukaryota.
DR   eggNOG; KOG1152; Eukaryota.
DR   GeneTree; ENSGT00940000159035; -.
DR   HOGENOM; CLU_006086_0_0_1; -.
DR   InParanoid; Q96RG2; -.
DR   OMA; NPDLYFS; -.
DR   OrthoDB; 297397at2759; -.
DR   PhylomeDB; Q96RG2; -.
DR   TreeFam; TF323242; -.
DR   PathwayCommons; Q96RG2; -.
DR   SignaLink; Q96RG2; -.
DR   SIGNOR; Q96RG2; -.
DR   BioGRID-ORCS; 23178; 13 hits in 1113 CRISPR screens.
DR   ChiTaRS; PASK; human.
DR   EvolutionaryTrace; Q96RG2; -.
DR   GeneWiki; PASK; -.
DR   GenomeRNAi; 23178; -.
DR   Pharos; Q96RG2; Tchem.
DR   PRO; PR:Q96RG2; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q96RG2; protein.
DR   Bgee; ENSG00000115687; Expressed in right uterine tube and 123 other tissues.
DR   ExpressionAtlas; Q96RG2; baseline and differential.
DR   Genevisible; Q96RG2; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0097009; P:energy homeostasis; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0045719; P:negative regulation of glycogen biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; TAS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0070092; P:regulation of glucagon secretion; ISS:UniProtKB.
DR   GO; GO:0043576; P:regulation of respiratory gaseous exchange; ISS:UniProtKB.
DR   CDD; cd00130; PAS; 2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF13426; PAS_9; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00091; PAS; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50112; PAS; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Cytoplasm;
KW   Kinase; Lipid-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..1323
FT                   /note="PAS domain-containing serine/threonine-protein
FT                   kinase"
FT                   /id="PRO_0000086480"
FT   DOMAIN          119..190
FT                   /note="PAS 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          335..402
FT                   /note="PAS 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          999..1251
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          20..47
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          837..857
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1298..1323
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1128
FT                   /note="Proton acceptor"
FT   BINDING         1005..1013
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         1028
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         1082..1089
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         1146
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         19
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CEE6"
FT   MOD_RES         34
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CEE6"
FT   MOD_RES         582
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         939
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1161
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:11459942"
FT   MOD_RES         1165
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:11459942"
FT   VAR_SEQ         1111
FT                   /note="Q -> QVRAGQSR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8590280"
FT                   /id="VSP_009302"
FT   VAR_SEQ         1112..1143
FT                   /note="LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIK -> VRAGQSRVSVNAGLGA
FT                   WVRWLQRSVIHTRFSL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045543"
FT   VAR_SEQ         1144..1323
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045544"
FT   VARIANT         11
FT                   /note="E -> K (in a metastatic melanoma sample; somatic
FT                   mutation; dbSNP:rs1277219458)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040986"
FT   VARIANT         250
FT                   /note="V -> I (in dbSNP:rs1470414)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_028293"
FT   VARIANT         426
FT                   /note="Q -> R (in dbSNP:rs35187712)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040987"
FT   VARIANT         512
FT                   /note="T -> A (in dbSNP:rs56033464)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040988"
FT   VARIANT         514
FT                   /note="L -> S (in dbSNP:rs2240543)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_028294"
FT   VARIANT         684
FT                   /note="P -> R (in dbSNP:rs56372985)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040989"
FT   VARIANT         694
FT                   /note="V -> M (in dbSNP:rs6727226)"
FT                   /evidence="ECO:0000269|PubMed:8590280"
FT                   /id="VAR_028295"
FT   VARIANT         725
FT                   /note="G -> D (in dbSNP:rs2005771)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_028296"
FT   VARIANT         796
FT                   /note="E -> K (in dbSNP:rs35129131)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040990"
FT   VARIANT         844
FT                   /note="P -> Q (in dbSNP:rs36082918)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040991"
FT   VARIANT         937
FT                   /note="R -> H (in dbSNP:rs56139954)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040992"
FT   VARIANT         1210
FT                   /note="V -> M (in dbSNP:rs10167000)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_028297"
FT   VARIANT         1266
FT                   /note="F -> C (in dbSNP:rs1131293)"
FT                   /evidence="ECO:0000269|PubMed:11459942,
FT                   ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8590280"
FT                   /id="VAR_028298"
FT   VARIANT         1301
FT                   /note="P -> S"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040993"
FT   MUTAGEN         1028
FT                   /note="K->R: Loss of autophosphorylating activity."
FT                   /evidence="ECO:0000269|PubMed:11459942,
FT                   ECO:0000269|PubMed:20943661"
FT   MUTAGEN         1058
FT                   /note="R->A: Induces lower protein kinase activity."
FT                   /evidence="ECO:0000269|PubMed:20943661"
FT   MUTAGEN         1058
FT                   /note="R->K: Does not affect protein kinase activity."
FT                   /evidence="ECO:0000269|PubMed:20943661"
FT   MUTAGEN         1151
FT                   /note="A->K: Induces lower protein kinase activity and
FT                   ability to autophosphorylate."
FT                   /evidence="ECO:0000269|PubMed:20943661"
FT   MUTAGEN         1152
FT                   /note="Y->F: Induces lower protein kinase activity."
FT                   /evidence="ECO:0000269|PubMed:20943661"
FT   MUTAGEN         1161
FT                   /note="T->A: Loss of catalytic activity (PubMed:11459942).
FT                   According to another report, does not affect the protein
FT                   kinase activity (PubMed:20943661). Does not affect protein
FT                   translation."
FT                   /evidence="ECO:0000269|PubMed:11459942,
FT                   ECO:0000269|PubMed:17595531, ECO:0000269|PubMed:20943661"
FT   MUTAGEN         1165
FT                   /note="T->A: Loss of catalytic activity. Does not affect
FT                   protein translation."
FT                   /evidence="ECO:0000269|PubMed:11459942,
FT                   ECO:0000269|PubMed:17595531"
FT   CONFLICT        205
FT                   /note="S -> T (in Ref. 2; BAA09484)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        407
FT                   /note="S -> C (in Ref. 4; CAH18087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        623
FT                   /note="S -> R (in Ref. 2; BAA09484)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        741
FT                   /note="W -> R (in Ref. 4; CAH18087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        850
FT                   /note="T -> M (in Ref. 2; BAA09484)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        899
FT                   /note="Y -> H (in Ref. 1; AAK69752)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1048
FT                   /note="K -> E (in Ref. 4; CAH18087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1062
FT                   /note="A -> S (in Ref. 7; AAH50565)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1129
FT                   /note="I -> F (in Ref. 8; AAB50198)"
FT                   /evidence="ECO:0000305"
FT   STRAND          133..141
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   STRAND          144..147
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   HELIX           151..155
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   TURN            159..161
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   HELIX           167..170
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   TURN            174..176
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   HELIX           177..181
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   TURN            182..184
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   STRAND          188..191
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   STRAND          193..195
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   STRAND          198..203
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   STRAND          211..214
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   STRAND          217..219
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   STRAND          222..225
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   STRAND          227..234
FT                   /evidence="ECO:0007829|PDB:1LL8"
FT   HELIX           987..991
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           994..998
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   STRAND          999..1004
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   STRAND          1006..1010
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   STRAND          1012..1018
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   TURN            1019..1022
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   STRAND          1023..1032
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   STRAND          1039..1043
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   TURN            1044..1046
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   STRAND          1047..1050
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1051..1056
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   STRAND          1067..1072
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   STRAND          1074..1082
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1090..1095
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1102..1121
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1131..1133
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   STRAND          1134..1136
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   STRAND          1142..1144
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1166..1168
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1171..1174
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1182..1198
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1206..1209
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   TURN            1210..1212
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1222..1231
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1236..1238
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1242..1247
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   TURN            1249..1252
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1257..1259
FT                   /evidence="ECO:0007829|PDB:3DLS"
FT   HELIX           1262..1265
FT                   /evidence="ECO:0007829|PDB:3DLS"
SQ   SEQUENCE   1323 AA;  142929 MW;  F8A3633CC6F6C8CD CRC64;
     MEDGGLTAFE EDQRCLSQSL PLPVSAEGPA AQTTAEPSRS FSSAHRHLSR RNGLSRLCQS
     RTALSEDRWS SYCLSSLAAQ NICTSKLHCP AAPEHTDPSE PRGSVSCCSL LRGLSSGWSS
     PLLPAPVCNP NKAIFTVDAK TTEILVANDK ACGLLGYSSQ DLIGQKLTQF FLRSDSDVVE
     ALSEEHMEAD GHAAVVFGTV VDIISRSGEK IPVSVWMKRM RQERRLCCVV VLEPVERVST
     WVAFQSDGTV TSCDSLFAHL HGYVSGEDVA GQHITDLIPS VQLPPSGQHI PKNLKIQRSV
     GRARDGTTFP LSLKLKSQPS SEEATTGEAA PVSGYRASVW VFCTISGLIT LLPDGTIHGI
     NHSFALTLFG YGKTELLGKN ITFLIPGFYS YMDLAYNSSL QLPDLASCLD VGNESGCGER
     TLDPWQGQDP AEGGQDPRIN VVLAGGHVVP RDEIRKLMES QDIFTGTQTE LIAGGQLLSC
     LSPQPAPGVD NVPEGSLPVH GEQALPKDQQ ITALGREEPV AIESPGQDLL GESRSEPVDV
     KPFASCEDSE APVPAEDGGS DAGMCGLCQK AQLERMGVSG PSGSDLWAGA AVAKPQAKGQ
     LAGGSLLMHC PCYGSEWGLW WRSQDLAPSP SGMAGLSFGT PTLDEPWLGV ENDREELQTC
     LIKEQLSQLS LAGALDVPHA ELVPTECQAV TAPVSSCDLG GRDLCGGCTG SSSACYALAT
     DLPGGLEAVE AQEVDVNSFS WNLKELFFSD QTDQTSSNCS CATSELRETP SSLAVGSDPD
     VGSLQEQGSC VLDDRELLLL TGTCVDLGQG RRFRESCVGH DPTEPLEVCL VSSEHYAASD
     RESPGHVPST LDAGPEDTCP SAEEPRLNVQ VTSTPVIVMR GAAGLQREIQ EGAYSGSCYH
     RDGLRLSIQF EVRRVELQGP TPLFCCWLVK DLLHSQRDSA ARTRLFLASL PGSTHSTAAE
     LTGPSLVEVL RARPWFEEPP KAVELEGLAA CEGEYSQKYS TMSPLGSGAF GFVWTAVDKE
     KNKEVVVKFI KKEKVLEDCW IEDPKLGKVT LEIAILSRVE HANIIKVLDI FENQGFFQLV
     MEKHGSGLDL FAFIDRHPRL DEPLASYIFR QLVSAVGYLR LKDIIHRDIK DENIVIAEDF
     TIKLIDFGSA AYLERGKLFY TFCGTIEYCA PEVLMGNPYR GPELEMWSLG VTLYTLVFEE
     NPFCELEETV EAAIHPPYLV SKELMSLVSG LLQPVPERRT TLEKLVTDPW VTQPVNLADY
     TWEEVFRVNK PESGVLSAAS LEMGNRSLSD VAQAQELCGG PVPGEAPNGQ GCLHPGDPRL
     LTS
//
